1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

ValGenesis Announces Strategic Partnership with Validator K.K. to Expand in Japan

04 Jul 2024
Admin
News Article

ValGenesis Announces Strategic Partnership with Validator K.K. to Expand in Japan

Overview

ValGenesis Inc., a leading provider of enterprise validation lifecycle management systems (VLMS), has announced a strategic reseller partnership with Validator K.K., a reputable Japanese company known for its validation products and services. This collaboration leverages Validator’s on-site validation services to benefit the Japanese life sciences sector.

About Validator K.K.

Established in 2015, Validator has earned recognition for its commitment to quality and continuous improvement, evidenced by its ISO9001 certification.
Their innovative business model focuses on providing on-site validation services, which has been well-received by companies struggling to secure in-house validation staff, facing high travel costs, or requiring specialized expertise for equipment.

About ValGenesis

ValGenesis is a pioneer in the field of digitized validation, offering a platform that includes its flagship VLMS product.
This platform is utilized in over 100,000 GMP systems worldwide, helping life sciences companies enhance their digital transformation strategies, ensure compliance, and standardize processes with a fully digital, risk-based validation approach.

Validator’s Services

Validator’s services address key issues in the pharmaceutical industry, making them a preferred partner in Japanese life sciences.
As a reseller partner of ValGenesis in Japan, customers can benefit from Validator’s on-site services combined with ValGenesis's digital validation platform.

Partnership Benefits

This partnership provides unique advantages to Validator’s customers, such as on-demand expertise with flexible scalability, comprehensive risk management, increased budget flexibility, and improved quality assurance.

From the SVP of Partners at ValGenesis

“Japan is a critical market for ValGenesis, being the world’s second-largest pharma and medtech market and a key innovation center for the global life sciences industry. We are honored to enter this market through a reliable partner like Validator,” said Bo Olsen, SVP of Partners at ValGenesis.
“With Validator’s on-site service model, customers can now access world-class solutions like ValGenesis VLMS, supporting digital transformation and adding value to validation and manufacturing processes. Our partnership with Validator offers a tailored approach to digitization for Japan’s unique conditions and industry needs.”

Statement from Validator K.K., Japan

“We are excited about this collaboration with ValGenesis, a leader in validation lifecycle management systems. Although paper-based validation is still common in Japan, recent GMP audit updates are pushing its limits. This partnership allows us to meet customer and government requirements through ValGenesis VLMS,” said Tamura Hiroki, Representative Director of Validator K.K., Japan.
“Japan’s leading position in the global pharmaceutical market is driven by relentless R&D and quality control efforts. With a shrinking population and labor shortage, productivity improvements are essential. Digital transformation is necessary for sustainable growth.”